Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Acclinate
United States
- Birmingham, AL
- 08/05/2024
- Series A
- $17,000,000
Our vision is health equity through inclusive research. We help pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.
- Industry Biotechnology
- Website https://www.acclinate.com/
- LinkedIn https://www.linkedin.com/company/acclinateinc/
Related People
Del Smith, PhDFounder
United States -
Birmingham, Alabama
Dr. Del Smith uses his diverse background in healthcare, IT, higher education, and business to drive greater healthcare equity. He is the CEO and Cofounder of Acclinate, a company using sustained community engagement and AI to mobilize historically marginalized communities for greater equity in healthcare.
Prior to cofounding Acclinate, Del dedicated nearly fifteen years to higher education as a business professor and then Dean of a business school. His research on success factors of minority-owned businesses has been published in journals such as the Journal of Business Research and the Journal of Developmental Entrepreneurship.
Del is a U.S. Army veteran and holds a Ph.D. in Business from the University of Alabama.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)